Meller J - Search Results

1

How reliable is secondary risk stratification with stimulated thyroglobulin in patients with differentiated thyroid carcinoma? Results from a retrospective study.

Lemb J, Hüfner M, Meller B, Homayounfar K, Sahlmann C, Meller J. Lemb J, et al. Among authors: meller b, meller j. Nuklearmedizin. 2013;52(3):88-96. doi: 10.3413/Nukmed-0517-12-07. Epub 2013 Feb 1. Nuklearmedizin. 2013. PMID: 23681150 Clinical Trial.

2

[Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma].

Sahlmann CO, Schreivogel I, Angerstein C, Siefker U, Lehmann K, Altenvoerde G, Hüfner M, Meller J. Sahlmann CO, et al. Among authors: meller j. Nuklearmedizin. 2003;42(2):71-7. Nuklearmedizin. 2003. PMID: 12695789 German.

3

Quantitative thyroid scintigraphy for the differentiation of Graves' disease and hyperthyroid autoimmune thyroiditis.

Sahlmann CO, Siefker U, Lehmann K, Harms E, Conrad M, Meller J. Sahlmann CO, et al. Among authors: meller j. Nuklearmedizin. 2004 Aug;43(4):124-8. doi: 10.1267/nukl04040124. Nuklearmedizin. 2004. PMID: 15316579

4

Expression of the sodium iodide symporter in differentiated thyroid cancer: clinical evidence.

Schmitz G, Füzesi L, Struck J, Siefker U, Hamann A, Sahlmann CO, Hüfner M, Meller J. Schmitz G, et al. Among authors: meller j. Nuklearmedizin. 2005;44(3):86-93. doi: 10.1267/nukl05030086. Nuklearmedizin. 2005. PMID: 15968416

5

Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.

Meller B, Sahlmann C, Horstmann O, Gerl J, Baehre M, Meller J. Meller B, et al. Among authors: meller j. Nuklearmedizin. 2005;44(3):N23-5. Nuklearmedizin. 2005. PMID: 15997503 No abstract available.

6

Diagnostic 123I and 131I activities and radioiodine therapy. Effects on urinary iodine excretion in patients with differentiated thyroid carcinoma.

Meller B, von Hof K, Genina E, Deisting W, Meller J, Richter E, Baehre M. Meller B, et al. Among authors: meller j. Nuklearmedizin. 2005;44(6):243-8. Nuklearmedizin. 2005. PMID: 16400384

7

Patients with autoimmune thyroiditis. Prevalence of benign lymphadenopathy.

Sahlmann CO, Meller J, Siggelkow H, Homayounfar K, Ozerden M, Braune I, Kluge G, Meller B. Sahlmann CO, et al. Among authors: meller b, meller j. Nuklearmedizin. 2012;51(6):223-7. doi: 10.3413/Nukmed-0484-12-03. Epub 2012 Oct 1. Nuklearmedizin. 2012. PMID: 23042429

8

See the unseen: Mesorectal lymph node metastases in prostate cancer.

Hijazi S, Meller B, Leitsmann C, Strauss A, Ritter C, Lotz J, Meller J, Trojan L, Sahlmann CO. Hijazi S, et al. Among authors: meller b, meller j. Prostate. 2016 Jun;76(8):776-80. doi: 10.1002/pros.23168. Epub 2016 Feb 16. Prostate. 2016. PMID: 26880517

9

[Effectiveness of goiter treatment with L-thyroxine in patients over 40].

Wollmann B, Meller J, Hüfner M, Becker W. Wollmann B, et al. Among authors: meller j. Nuklearmedizin. 1998 Jan;37(1):41-4. Nuklearmedizin. 1998. PMID: 9467169 German.

10

[Clinical implications of a new TSH receptor antibody assay (DYNOtest TRAKhuman) in autoimmune thyroid diseases].

Meller J, Schreivogel I, Bergmann A, Morgenthaler N, Hüfner M, Becker W. Meller J, et al. Nuklearmedizin. 2000;39(1):14-8. Nuklearmedizin. 2000. PMID: 10726252 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters